Farid Adrienne
SEC CIK 1867310 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| IPSC | Century Therapeutics, Inc. | Chief Ops Off | 250.1K | — | $297.0K | 15 | 2023-02-02 | 2025-06-09 |
Most active insiders at IPSC, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Pfeiffenberger Brent | Pres, CEO, Dir | $47.7K | $14.6K |
| 2 | Cowan Chad | CSO | $49.4K | $2,731 |
| 3 | Russotti Gregory | See Remarks | — | $40.2K |
| 4 | Carr Douglas | SVP Fin, Ops | — | $28.6K |
Farid Adrienne made no open-market trades at IPSC in the last 12 months.
Transactions 15
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-06-11 | 2025-06-09 | IPSC | Century Therapeutics, Inc. | Farid Adrienne | Chief Ops Off | S - Sale | $0.62 | -552 | 250.1K | -0.2% | -$342.24 | |
| 2025-05-07 | 2025-05-05 | IPSC | Century Therapeutics, Inc. | Farid Adrienne | Chief Ops Off | S - Sale | $0.55 | -1,024 | 250.7K | -0.4% | -$563.20 | |
| D | 2025-03-12 | 2025-03-10 | IPSC | Century Therapeutics, Inc. | Farid Adrienne | Chief Ops Off | S - Sale | $0.62 | -2,359 | 131.7K | -2% | -$1,463 |
| D | 2025-03-12 | 2025-03-11 | IPSC | Century Therapeutics, Inc. | Farid Adrienne | Chief Ops Off | A - Grant | $0.00 | +120.0K | 251.7K | +91% | $0 |
| 2025-02-05 | 2025-02-03 | IPSC | Century Therapeutics, Inc. | Farid Adrienne | Chief Ops Off | S - Sale | $0.78 | -1,054 | 134.1K | -0.8% | -$822.12 | |
| 2024-11-05 | 2024-11-04 | IPSC | Century Therapeutics, Inc. | Farid Adrienne | Chief Ops Off | S - Sale | $1.23 | -1,033 | 135.1K | -0.8% | -$1,271 | |
| 2024-08-07 | 2024-08-05 | IPSC | Century Therapeutics, Inc. | Farid Adrienne | Chief Ops Off | S - Sale | $1.83 | -1,073 | 136.2K | -0.8% | -$1,964 | |
| 2024-05-07 | 2024-05-03 | IPSC | Century Therapeutics, Inc. | Farid Adrienne | Chief Ops Off | S - Sale | $3.11 | -913 | 137.2K | -0.7% | -$2,839 | |
| D | 2024-03-11 | 2024-03-07 | IPSC | Century Therapeutics, Inc. | Farid Adrienne | Chief Ops Off | A - Grant | $0.00 | +24.0K | 138.1K | +21% | $0 |
| DM | 2024-03-08 | 2024-03-06+ | IPSC | Century Therapeutics, Inc. | Farid Adrienne | Chief Ops Off | M - OptEx | $1.03 | +53.5K | 144.8K | +59% | +$55.1K |
| DM | 2024-03-08 | 2024-03-06+ | IPSC | Century Therapeutics, Inc. | Farid Adrienne | Chief Ops Off | S - Sale+OE | $5.04 | -53.5K | 114.1K | -32% | -$269.5K |
| D | 2024-02-21 | 2024-02-16 | IPSC | Century Therapeutics, Inc. | Farid Adrienne | Chief Ops Off | S - Sale+OE | $4.86 | -485 | 114.1K | -0.4% | -$2,357 |
| D | 2024-02-21 | 2024-02-16 | IPSC | Century Therapeutics, Inc. | Farid Adrienne | Chief Ops Off | M - OptEx | $1.03 | +485 | 114.6K | +0.4% | +$499.55 |
| M | 2024-02-07 | 2024-02-05+ | IPSC | Century Therapeutics, Inc. | Farid Adrienne | Chief Ops Off | S - Sale | $4.14 | -3,819 | 114.1K | -3% | -$15.8K |
| DM | 2023-02-06 | 2023-02-02 | IPSC | Century Therapeutics, Inc. | Farid Adrienne | Chief Ops Off | A - Grant | $0.00 | +43.8K | 96.1K | +84% | $0 |
Purchase Sale Sale after option exercise All abbreviations